CAS, Molecule.one to collaborate on advanced synthesis design technologies
In a significant development in the realm of drug discovery, CAS, a subsidiary of the American Chemical Society, has teamed up with tech-bio front-runner Molecule.one. The focus of this strategic collaboration is the development of computer-aided synthesis design technologies. By harnessing the prowess of Molecule.one’s proprietary AI models and CAS’ vast chemical reaction content, the […]